QVR’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

QVR’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-49,200	Closed	-$4.68M	–	49
2019 Q4	$4.68M	Buy	+49,200	New	+$4.26M	0.88%	18
2019 Q3	–	Sell	-8,600	Closed	-$754K	–	74
2019 Q2	$754K	Sell	8,600 -194,700	-96%	-$16.6M	0.1%	67
2019 Q1	$18.4M	Buy	203,300 +185,200	+1,023%	+$15.8M	2.55%	10
2018 Q4	$1.3M	Buy	+18,100	New	+$1.46M	0.29%	53

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

QVR's XBI Position: Q3 2019 in Review

QVR sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2019, closing a stake of 32,237 shares — an estimated $2.83M sold.

QVR first reported a position in XBI in Q4 2017 and held it in 4 quarters. The position peaked at $8.17M in Q4 2017. 406 funds tracked by Wall St. Rank hold XBI as of Q3 2019.

QVR reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2019 after selling out during the quarter.
QVR sold 32,237 State Street SPDR S&P Biotech ETF shares in Q3 2019, an estimated $2.83M.
QVR first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and held it in 4 quarters.
QVR's State Street SPDR S&P Biotech ETF position peaked at $8.17M in Q4 2017.
406 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2019.

Based on QVR's 13F filing for Q3 2019, filed 1 Nov 2019.